IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q3 2019 Holdings

Filed 2019-11-14 | 6 holdings | $30.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Axogen Inc(AXGN)COM05463X106$30.3M2,429,99999.6%
Eyepoint Pharmaceuticals IncCOM30233G100$75.9K41,909,2190.2%
Revance Therapeutics Inc(RVNCEUR)COM761330109$43.4K3,342,0470.1%
Medicinova Inc(MNOV)COM NEW58468P206$9.5K1,170,3700.0%
Endologix Inc(ELGXEUR)COM NEW29266S304$998125,7470.0%
Catalyst Biosciences IncCOM NEW14888D208$38678,6220.0%